Mon.May 05, 2025

article thumbnail

Three CAR-T therapies forecasted to capture over 70 per cent of T-Cell immunotherapy market in 2025

Express Pharma

T-cell immunotherapies (TCI) are redefining cancer care, with chimeric antigen receptor T-cell (CAR-T) therapies witnessing significant momentum. In 2025, just three drugs- Carvykti by Legend Biotech, Yescarta by Gilead Sciences, and Breyanzi by Bristol-Myers Squibb (BMS) are expected to capture over 70 per cent of the global T-cell immunotherapy market, according to GlobalData.

65
article thumbnail

Shingles vaccine lowers the risk of heart disease for up to eight years

World Pharma News

People who are given a vaccine for shingles have a 23% lower risk of cardiovascular events, including stroke, heart failure, and coronary heart disease, according to a study of more than a million people published in the European Heart Journal. The protective effect of the vaccine lasts for up to eight years and is particularly pronounced for men, people under the age of 60 and those with unhealthy lifestyles, such as smoking, drinking alcohol and being inactive.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Roquette restructures company, appoints new leaders following the acquisition of IFF Pharma Solutions

Express Pharma

Roquette, a provider of plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces a new organisation following its acquisition of IFF Pharma Solutions, announced on May 1. The new organisation aims to enhance agility and customer responsiveness. Now with over 11,000 employees, 40 manufacturing sites and a network of global R&D and Innovation Centres, the company aims to expand its global footprint and the diversity of its portfolio.

article thumbnail

STAT+: As financial prospects for gene therapies dim, an ambitious charity picks up the torch  

STAT

MILAN — For more than three decades, a charity here has funded research aimed at developing medicines for genetic diseases. Recently, though, it added an unusual new role — as a gene therapy company of sorts.  The charity, the Telethon Foundation, took ownership from a small biotech of a drug that has been approved in Europe to treat an ultra-rare immune disorder called ADA-SCID.

Immunity 343
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

TPG acquires 35% stake in SCHOTT Poonawalla JV

Express Pharma

SCHOTT Pharma announced that TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35 per cent stake in its joint venture, SCHOTT Poonawalla, from Serum Institute of India (SII). SCHOTT Poonawalla is a joint venture of SCHOTT Pharma and SII, part of the Cyrus Poonawalla Group. TPG Growth, TPGs middle market and growth equity platform, is funding the investment, along with Novo Holdings as a co-investor.

More Trending

article thumbnail

With compounders out of the way, Lilly and Novo go after each other

PharmaVoice

The two obesity leaders are pulling on all levers to stay on top of the market.

article thumbnail

STAT+: Charles Lieber, ex-Harvard chemist convicted of lying about ties to China, joins faculty of Chinese university

STAT

Charles Lieber, the former chair of Harvard’s chemistry department and renowned nanoscientist who was  convicted of lying to federal agents about his ties to China , was recently announced as a new professor at a Chinese university. Lieber joined the full-time faculty at Tsinghua Shenzhen International Graduate School on April 28 and was appointed to Tsinghua University‘s highest faculty position, the university  announced  this month.

294
294
article thumbnail

AI specialist Recursion trims pipeline in latest shakeup

BioPharma Dive

The cuts to three advanced drug programs were “inevitable” given the company’s “unsustainable cash burn,” one analyst wrote in a note to investors.

118
118
article thumbnail

Opinion: STAT+: Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy

STAT

Having grown up in rural Arkansas, I have an acute awareness of the challenges many in our country face when it comes to health care. Quality care wasn’t always accessible, and the decision of whether to pay medical or utility bills was a real dilemma for my family and others in our community. That is why bringing transformational medicines to patients and advocating for policies that ensure these medicines are rapidly and widely available are so important to me and my 30,000 colleagues.

287
287
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

After an up and down year, pharma’s R&D landscape is shifting again

PharmaVoice

While clinical trial funding was up, deal-making was down, and new uncertainties are coming into the picture.

100
100
article thumbnail

Opinion: STAT+: A court decision on lab-developed tests sets a dangerous precedent

STAT

It’s no secret that the new administration has upset normal operations at the Food and Drug Administration: Thousands of employees have been terminated , more than three dozen senior officials are gone , day-to-day operations ranging from communicating product recalls to the public to inspections of food and drug facilities have been upended , and approvals of new products and technologies have been delayed and shelved.

article thumbnail

FDA accepts Novo Nordisk’s NDA submission for weight management therapy

Pharmaceutical Technology

The US FDA has accepted Novo Nordisks new drug application (NDA) submission for the 25 mg oral formulation of Wegovy (semaglutide).

97
article thumbnail

FDA will ask outside experts to review Capricor’s therapy for Duchenne muscular dystrophy

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Today, we explore how an ambitious nonprofit is taking control of a shelved gene therapy, as it seeks to create a new model for commercializing treatments no longer deemed lucrative by pharma. Also, we see global scientific worry over internal NIH emails that say international collaborations may be cut off.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Deerfield secures more than $600M for its next biotech venture fund

BioPharma Dive

The firm, a prolific backer of drug startups, will use the cash to back companies working on therapeutics, medical devices and healthcare services.

93
article thumbnail

STAT+: 5 food experts making sense of MAHA’s vision for a new way of eating

STAT

Here are a few things we know about how Robert F. Kennedy eats. He likes raw milk , full-fat dairy, and intermittent fasting. He’s suspicious of artificial food dyes and seed oils, and says “ sugar is poison.” He doesn’t drink alcohol. If he spots roadkill, he may try to eat it , though not right away. The health secretary’s personal nutrition views and habits matter because they have direct bearing on the policies of his Make America Healthy Again movement, wh

197
197
article thumbnail

Akums’ gains patent for Tablet-in-Tablet technology for NVP medication

Express Pharma

Akums Drugs & Pharmaceuticals has been granted a patent for its extended-release formulation of Doxylamine and Pyridoxine, designed specifically to address nausea and vomiting in pregnancy (NVP). Akums’ tablet-in-tablet technology combines an outer layer that provides immediate drug release for rapid relief from nausea, with an inner core designed for sustained release, ensuring a longer therapeutic effect.

90
article thumbnail

STAT+: Vertex reports an earnings miss and pause on cystic fibrosis trial

STAT

Vertex Pharmaceuticals on Monday reported disappointing first-quarter earnings impacted by weaker-than-expected sales of its drugs for cystic fibrosis, and little or no contributions from a gene therapy for sickle cell disease and a recently launched pain medicine.  A “tolerability issue” caused a temporary pause to an early stage study involving a closely watched, inhaled, mRNA-based therapy for cystic fibrosis, the company said.

154
154
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

PTC stock slides on new data for Huntington’s drug

BioPharma Dive

While updated study results confirmed the drug lowers a target protein, the therapy's effect on clinical outcomes was less clear-cut.

70
article thumbnail

Women’s Health Initiative — and its 42,000 volunteers — still in limbo

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Hi, Morning Rounds editor Karen Pennar, back again. First off, an update to Friday’s newsletter item on NIH’s freeze of subawards to foreign scientists: Megan Molteni has learned that privately, NIH leadership is making it clear that the moves are part of a broader America First agenda that seeks to dramatically reduce U.S. participation in international s

150
150
article thumbnail

GLP-1R agonists can redefine chronic disease treatment beyond diabetes and obesity

Express Pharma

GLP-1 receptor agonists, once focused on treating diabetes and obesity, are now emerging as potential treatments for a broader range of chronic conditions, including Alzheimers disease. As evidence builds around their wider therapeutic benefits, particularly in targeting insulin resistance, drug developers are accelerating efforts to expand their use and potentially transform how multiple high-burden diseases are managed, according to GlobalData.

article thumbnail

New J&J data signals progress in ulcerative colitis treatment landscape

European Pharmaceutical Review

New clinical findings show that Johnson & Johnsons monoclonal antibody Tremfya (guselkumab) enabled sustained clinical and endoscopic efficacy for ulcerative colitis patients at two years. This is based on the long-term extension study of the Phase III QUASAR trial , which evaluated adults with moderately-to-severely active forms of the disease.

64
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

PBMs launch new ad campaign to block reforms

PhRMA

PBM’s trade association, PCMA, recently launched a campaign to mask growing concerns over their role in the pharmaceutical supply chain and the rising cost of medicine for patients. The campaign is in response to elected officials nationwide joining the congressional momentum in calling for PBM reform. It’s time to rein in middlemen, like PBMs, who use medicines as a profit center and drive up the costs for patients, employers, and taxpayers.

63
article thumbnail

Novel Pharmaceutical Strategies and Business Models: The Rise of Telehealth Companies Like Ro and Hims & Hers

Drug Patent Watch

"The Telehealth Revolution: How D2C Pharmacies Are Redefining the Industry In a seismic shift, direct-to-consumer (D2C) pharmacies like Ro, Hims, and Hers are upending traditional healthcare business models, leveraging telehealth to deliver convenient, affordable, and personalized care to millions. But what's driving this transformation, and what does it mean for the future of pharmaceuticals?

63
article thumbnail

FDA decision on oral Wegovy coming in Q4

pharmaphorum

FDA decision on oral Wegovy coming in Q4 Jonah.

59
article thumbnail

Exploring the Role of South Africa in the Global Pharmaceutical Landscape

Drug Patent Watch

"As the world grapples with the complexities of global healthcare, one nation is rewriting the rules of the pharmaceutical game: South Africa. In a groundbreaking new report, we delve into the pivotal role the country is playing in shaping the future of medicine. From pioneering generic drug production to challenging Big Pharma's dominance, South Africa is redefining what it means to be a leader in the global pharmaceutical landscape.

55
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Asembia 2025: Designing Smarter Interventions with Community Insights

Pharmaceutical Commerce

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are key to closing persistent gaps in preventive care and healthcare access.

52
article thumbnail

Asembia 2025: Designing Smarter Interventions with Community Insights

PharmExec

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are key to closing persistent gaps in preventive care and healthcare access.

52
article thumbnail

Asembia 2025: Why AI Could Be the Key to Solving Access Challenges in Healthcare

Pharmaceutical Commerce

Chip Parkinson, CEO, GiftHealth, explains how AI-powered data integration is bringing new hope to patients by revealing hidden access barriers, streamlining treatment pathways, and challenging outdated utilization management practices.

52